AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Pirfetab Tablet

Prescription Icon
Prescription Required

Marketer

Zydus Cadila

Salt Composition

Pirfenidone (200mg)

Overview Pirfetab Tablet

Nintedanib (Pirfetab Tablet) is a prescription medication indicated for idiopathic pulmonary fibrosis. This treatment mitigates lung inflammation and fibrosis, improving respiratory function. For optimal absorption, consume Nintedanib with food, adhering to a consistent daily schedule. Dosage frequency varies depending on individual needs, determined by your physician to manage your symptoms effectively. Continue the prescribed treatment duration. Commonly reported adverse effects include sleep disturbances, headache, vertigo, indigestion, nausea, diarrhea, and sun sensitivity. To minimize dizziness-related risks, refrain from driving or activities requiring focused attention. Weight loss may occur; regular monitoring or consultation with your physician is advised. Liver function testing may be conducted during treatment. Prior to initiating Nintedanib, disclose any existing liver or kidney conditions, as well as all concurrent medications, since interactions can affect efficacy or alter its action. Due to increased sun sensitivity, utilize protective clothing and sunscreen during sun exposure. Disclose pregnancy or breastfeeding status to your doctor.

Primary Ingredients of Pirfetab Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Pirfetab Tablet

Managing idiopathic pulmonary fibrosis

Major Benefits of Pirfetab Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Pirfetab should be administered with food.

Common Side effects of Pirfetab Tablet:

  • Insomnia (difficulty in sleeping)
  • Headache
  • Dizziness
  • Tiredness
  • Sinus inflammation
  • Loss of appetite
  • Upper respiratory tract infection
  • Weight loss
  • Nausea
  • Indigestion
  • Diarrhea
  • Photosensitivity

How to use Pirfetab Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Pirfetab Tablet with a meal.

How Pirfetab Tablet works:

Pirfetab tablets offer antifibrotic therapy. Their mechanism involves inhibiting a specific endogenous compound implicated in the fibrotic process. This action mitigates pulmonary scarring and inflammation, thereby improving respiratory function.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Pirfetab Tablet may pose unknown risks. Physician consultation is advised.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Pirfetab tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against the risks before prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Pirfetab Tablet use while breastfeeding is absent. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking Pirfetab Tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

Individuals with kidney impairment should exercise caution when using Pirfetab tablets, as dose modification may be necessary. Consultation with a physician is advised. Pirfetab tablets are contraindicated for patients with severe kidney disease or those undergoing dialysis.

LiverLiverCAUTION

Individuals with liver impairment should use Pirfetab tablets cautiously, potentially requiring dosage modifications. Consultation with a physician is advised. Pirfetab tablets are contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Pirfetab Tablet :

NA

Facts to Know About Pirfetab Tablet

LabelValue
Chemical Category Pyridone Derivative
Developing Habits No.
Type of Therapy Breathing
Actions Pulmonary fibrosis of unknown cause

FAQs on Pirfetab Tablet

Before starting Pirfetab Tablet treatment, your doctor will assess your liver function, with monthly checks for the first six months, then every three months thereafter. Lung function will also be monitored regularly to evaluate your response to the medication.
Protecting your irreplaceable lung function is crucial to managing disease progression. Therefore, consistently taking Pirfetab Tablets as directed by your doctor is strongly advised to help maintain your current lung capacity.
Pirfetab Tablet may cause common side effects like sun sensitivity, nausea, fatigue, diarrhea, indigestion, appetite loss, and headache. Other reported side effects include upper respiratory and bladder infections, weight loss, insomnia, dizziness, drowsiness, altered taste, hot flashes, shortness of breath, and cough. Gastrointestinal issues such as acid reflux, vomiting, bloating, abdominal pain, heartburn, and constipation may also occur. Skin reactions including itching, redness, dryness, and rash are possible, along with muscle pain, joint pain, weakness, chest pain, and sunburn. Elevated liver enzymes may be detected in blood tests.
Pirfetab tablets are not steroids; they're pyridines used to treat idiopathic pulmonary fibrosis (IPF) in adults. IPF causes lung tissue scarring and swelling, impairing breathing. Pirfetab helps alleviate these effects, improving respiratory function.
You and your doctor should determine together if Pirfetab Tablets are suitable for you. Your doctor will prescribe them only after evaluating your health. Continued use depends on your response and tolerance to the medication.
Idiopathic pulmonary fibrosis progresses unpredictably. Always consult your doctor before stopping Pirfetab Tablet, which helps slow disease progression.
To maximize Pirfetab Tablet effectiveness, minimize sun exposure by wearing sunscreen daily and protective clothing (covering arms, legs, and head). Additionally, avoid smoking.
While the average lifespan for pulmonary fibrosis patients is two to three years, many survive considerably longer. Reduced survival is associated with older age, smoking, and lower BMI. Further contributing factors include advanced disease severity (radiologically and functionally), and the onset of additional lung problems.
Pirfetab Tablet
266
MRP 307
13% off